Efficacy of thalidomide in refractory adult still's disease: A new case report [7]

Clinical and Experimental Rheumatology

Volumn 21, Issue 2, 2003, Pages 272-

  Meaux Ruault, N ^a   Magy, N ^a   Gil, H ^a   Dupond, Jean Louis ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; CORTICOSTEROID; ETANERCEPT; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; PREDNISONE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ADULT ONSET STILL DISEASE; AGE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG EFFICACY; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPERTHERMIA; LETTER; MALE; PERICARDITIS; PERIPHERAL NEUROPATHY; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; RASH; RELAPSE; TERATOGENICITY; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; STILL'S DISEASE, ADULT-ONSET; THALIDOMIDE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037367753     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. OHTA A, YAMAGUCHI M, KANEOKA H, NAGAYOSHI T, HIIDA M: Adult Still's disease: Review of 228 cases from the literature. J Rheumatol 1987; 14: 1139-46.
2. AKRITIDIS N, SAKKAS LI: Adult onset Still's disease. 16 cases. Presse Med 1995; 24: 1207-8.
3. DIAMOND JR: Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: Remission induced with intravenous immunoglobulin G. J Nephrol 1997; 10: 253-7.
4. VIGNES S, WECHSLER B, PIETTE JC: La maladie de Still. Rev Med Interne 1997; 18: 626-37.
5. CAVAGNA L, CAPORALI R, EPIS O, BOBBIO-PALLAVICINI F, MONTECUCCO C: Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 2001; 19: 329-32.
6. HUSNI ME, MAIER AL, MEASE PJ et al.: Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 2002; 46: 1171-6.
7. KAKLAMANI VG, KAKLAMANIS PG: Treatment of Behçet's disease - An update. Semin Arthritis Rheum 2001; 30: 299-312.
8. KEESAL N, WASSERMAN MJ, BOOKMAN A, LAPP V, WEBER DA, KEYSTONE EC: Thalidomide in the treatment of refractory rheumatoid arthritis. J Rheumatol 1999; 26: 2344-7.
9. BREBAN M, GOMBERT B, AMOR B, DOUGADOS M: Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis (letter). Arthritis Rheum 1999; 42:580-1.
10. YAMAGUCHI M, OHTA A, TSUNEMATSU T et al.: Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19:424-30.
11. MOREIRA AL, SAMPAIO EP, ZMUIDZINAS A, FRINDT P, SMITH KA, KAPLAN G: Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993; 177: 1675-80.
12. STAMBE C, WICKS IP: TNFα and response of treatment-resistant adult-onset still's disease to thalidomide. Lancet 1998; 352: 544-5.